Last week it was revealed that the Valneva Covid vaccine will first be made available to the UK after the European Union and President Emmanuel Macron did not pre-order the doses. The jabs have already been pre-ordered by Downing Street, with manufacturing taking place in Livingston, Scotland, illustrating even more evidence that the UK is ahead of rivals with its vaccination schedule. Brexit Britain has reportedly secured an order of 190 million doses over five years, with the first 60 million of the 100 million doses due to continue in the first quarter of next year, with the rest also due to be delivered in 2022.
UK authorities also have the option to deliver an additional 90million doses between 2023 and 2025, which would bring the total order value to Â£ 1.2 billion.
But in what has proven to be a major source of embarrassment for the EU and France, no deal has been reached with Valneva to deliver vaccine doses to the block.
Talks between the parties began at the beginning of last year but failed on the grounds that “the French company had not fulfilled the conditions” for marketing in Europe.
Today, the latest humiliating failure of the EU and France was brutally mocked by one of Frexit’s main activists.
Patrice Cali, figurehead of the Eurosceptic Republican Popular Union (UPR), was unleashed on Twitter: “Valneva (traditional vaccine, no RNA), a French success … from the EU!”
Last week, Foulques Combat de Lauwe, city councilor of Nantes, fulminated: âChronicle of European and French industrial and health myopia.
âValneva, a beautiful Nantes biotech, had everything to be the first to offer a French vaccine to Europeans.
âIt’s done, but for Great Britainâ¦ who left the EU!
READ MORE: Australian doctor issues stern warning about Delta Covid variant
Weeks later, 12 EU member states, including France, suggested they wanted to order the vaccines themselves rather than through the bloc’s supply system.
Valneva’s chief financial officer, David Lawrence, said the company was “in discussions with various governments.”
He added: He added: âWe believe our inactivated vaccine can make a major contribution to the ongoing fight against the pandemic and remain committed to bringing it to market. “
Paul Hunter, professor of medicine at the University of East Anglia and specialist in infectious diseases, said: âThe question is who is it for, as we have ordered more than enough Pfizer vaccine to immunize everyone. world. [in the UK] in autumn.
“I think we did that so that we could set it up and make it work and give it away or sell it to other countries afterwards.”
Additional reporting by Maria Ortega.